Skip to main content
TipRanks
Go Ultimate75% OFF

Amphastar Pharmaceuticals (AMPH) Q3 2023 Earnings Report

437 Followers

AMPH Q3 2023 EPS Results

Actual EPS
$1.15
Consensus EPS
$0.70
Beat/Miss
Beat by +$0.45
One Year Ago EPS
$0.38

AMPH Q3 2023 Revenue Results

Actual Revenue
$180.56M
Expected Revenue
$174.63M
Beat/Miss
Beat by +$5.93M
YoY Revenue Growth
+50.30%

Earnings Announcement Details

Quarter
Q3 2023
Date
11/08/2023
Time
After Close
Conference Call
Wednesday, November 8, 2023
AMPH Upcoming Earnings

Amphastar Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q3 2023 Earnings Call Audio

AMPH Q3 2023 Earnings Call
0:00 / 0:00

Q3 2023 Earnings Slide Deck

Q3 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

AMPH Earnings History

AMPH earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)0.79-0.73――
Nov 05, 20262026 (Q3)0.861.140.9322.58% (+0.21)
Aug 06, 20262026 (Q2)0.620.910.857.06% (+0.06)
May 07, 20262026 (Q1)0.700.420.74-43.24% (-0.32)
Feb 26, 20262025 (Q4)0.900.730.92-20.65% (-0.19)
Nov 06, 20252025 (Q3)0.820.930.96-3.13% (-0.03)
Aug 07, 20252025 (Q2)0.740.850.94-9.57% (-0.09)
May 07, 20252025 (Q1)0.690.741.04-28.85% (-0.30)
Feb 27, 20252024 (Q4)0.940.920.884.55% (+0.04)
Nov 06, 20242024 (Q3)0.990.961.15-16.52% (-0.19)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed